Focus

Pharma Investors: Angels and VC Firms

The RaiseHunt database lists 3,592 Pharma investors: 100 angel investors and 3,492 people at 1,040 firms. Most list Seed and Series A among their stages; the largest hubs are New York, London and Paris.

Strongest in New York, London and Paris

Common stages: Seed and Series A

3,592: Pharma investors
100: Angel investors
3,492: People at VC/PE firms
1,040: Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

3,592 Pharma investors

Showing 61-80

Filters

Viewing

Pharma3,592

Investor Type

Choosing one replaces Pharma.

See all 13→

Investment Stage

Choosing one replaces Pharma.

Seed84,744
Series A53,997
Late-Stage37,937
Series B35,865
Growth34,738
Pre-Seed32,476

See all 6→

Investment Profile

Choosing one replaces Pharma.

SaaS63,482
FinTech54,182
Healthcare53,462
Consumer46,735
AI46,188
Hardware36,507
Commerce32,773
Climate23,313
Real Estate17,905
Education13,608
Food10,848
Travel7,450
Energy946
Agriculture555

See all 14→

Country

Choosing one replaces Pharma.

See all 186→

City

Choosing one replaces Pharma.

See all 694→

Focus1

See all 802→

Investor	Location	Type	Markets	Actions
Abel S. Osorio Managing Partner at Turnspire Capital Partners	New York, United States	Private equity	FoodHardware	View profile
Christopher Ekdahl Partner at Nordic Capital	Stockholm, Sweden	Private equityVenture debt	ConsumerFinTech	View profile
Karen Spilizewski Managing Director at RiverVest Venture Partners	Cleveland, United States	Venture capital	HardwareHealthcare	View profile
Jennifer Williams Partner and CFO at Genesys Capital	Toronto, Canada	Corporate VCVenture capital	AIHealthcare	View profile
Daniel Bahcheli Director at RA Capital Management	Boston, United States	Private equityVenture capital	FinTechHealthcare	View profile
Matthew Hobart Co-Managing Partner, TPG Growth at TPG	San Francisco, United States	Private equityVenture debt	AIFinTech	View profile
Valentina Agostoni Principal at TVM Capital Life Science	Montreal, Canada	Venture capital	ConsumerHardware	View profile
Enzo Villani Chief Investment Officer at Alpha Compute	United States	Corporate VCVenture capital	AIConsumer	View profile
Tom Masterson Investor at Allele Capital Partners	Fort Lauderdale, United States	Private equityVenture debt	Healthcare	View profile
David Hickman Managing Director at Oxford Finance	San Diego, United States	Venture debt	FinTechHealthcare	View profile
Stefan Fischer Managing Partner (Finance) bei TVM Capital Life Science at TVM Capital Life Science	Munich, Germany	Venture capital	ConsumerHardware	View profile
Marco Baratti Investor at Star Capital Sgr	Milan, Italy	Private equityVenture capital	HardwareHealthcare	View profile
Matthew Hammond Partner at RA Capital Management	Boston, United States	Private equityVenture capital	FinTechHealthcare	View profile
Evan Kaufman Principal at TPG	New York, United States	Private equityVenture debt	AIFinTech	View profile
Minglin Ma Executive Director at Vertex Pharmaceuticals	Ithaca, United States	Corporate VCFamily Office	AIClimate	View profile
Heather Preston General Partner at Oxonian Ventures	San Francisco, United States	Private equityVenture capital	AIConsumer	View profile
Eric Veale Senior Director at Oxford Finance	Chicago, United States	Venture debt	FinTechHealthcare	View profile
Christopher Campbell Partner at CapVest	London, United Kingdom	Private equity	ConsumerFinTech	View profile
Michail Zekkos Partner@Permira, Technology Growth Investor at Permira	London, United Kingdom	Private equityVenture debt	AICommerce	View profile
Aaron Fisher Director at Archimed	New York, United States	Private equity	HardwareHealthcare	View profile

Data: RaiseHunt investor dataset · Snapshot 2 October 2026 · How this data is built · Report a correction or request removal